BioCentury
ARTICLE | Financial News

Lysogene completes IPO

February 10, 2017 9:50 PM UTC

Gene therapy company Lysogene S.A. (Euronext:LYS) raised €22.6 million ($24.3 million) through the sale of 3.3 million shares at €6.80 in an IPO underwritten by Société Générale and Gilbert Dupont on...

BCIQ Company Profiles

Lysogene S.A.